SecBot SecBot
DEFA14A ·Filed Apr 27, 2026

MGX

Metagenomi Therapeutics, Inc.
NEUTRAL
Impact 2/10
Horizonweeks Processed6mo ago SEC0001193125-26-182339
Proxy solicitation materials
Actionable Insight • Neutral

This DEFA14A is a routine administrative filing with no actionable content. Monitor for the definitive proxy statement (DEF 14A) which will contain actual voting items and meeting details. The stock's poor historical reaction to filings suggests caution on any bullish interpretation of proxy materials.

DirectionNeutral
Confidencelow
Horizonweeks
Final — all horizons settled through T+60d
MGX ▼ -15.28% at T+60d
NEUTRAL call -15.28% · α vs SPY -19.27% · entry $1.44 → $1.22
Entry = T+0 close
Apr 27, 2026
via day close
T+1d
-3.47%
call -3.47% · α -3.46%
$1.39
settled 6mo ago
T+5d
-2.08%
call -2.08% · α -3.78%
$1.41
settled 6mo ago
T+20d
-5.56%
call -5.56% · α -11.02%
$1.36
settled 5mo ago
T+60d
-15.28%
call -15.28% · α -19.27%
$1.22
settled 3mo ago

Price Chart

Loading chart...

Executive Summary

Metagenomi Therapeutics filed a DEFA14A (additional definitive proxy soliciting materials) on April 27, 2026. The filing contains no substantive financial data, no activist campaign details, and no specific voting items — it is a routine administrative filing with only boilerplate SEC header information and embedded graphic/XBRL documents. No material information for traders.

Key Facts

  • Filed DEFA14A on 2026-04-27 — additional definitive proxy soliciting materials
  • No specific proxy proposals, meeting date, or voting items disclosed in the filing text
  • No financial data, guidance, or material corporate events referenced
  • Market cap is $56M with 78% analyst bullish consensus (2 Strong Buy, 5 Buy, 2 Hold)

Financial Impact

No financial figures disclosed in the filing

Risk Factors

  • No material information in this filing — risk of over-interpreting routine proxy materials

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
78% bullish (9 analysts)

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
DEFA14A Filing (Primary)0001193125-26-182339
Document: 0001193125-26-182339-index-headers.html0001193125-26-182339
Document: 0001193125-26-182339-index.html0001193125-26-182339
Document: 0001193125-26-182339.txt0001193125-26-182339
14 reports for MGX
Performance horizon
67% Hit rate @ T+20 2 of 3 directional calls Went positive at some point 3 of 3 best @ T+20▲ +8.89%May 11, 2026
Filters
Rows
Reports for MGX — sortable, filterable
TypeNow
Sep 21, 2026
5w ago
8-K
NEUTRAL ★ 4/10
$1.14 $0.8310▼ −27.11%▼ −26.55%$0.8000 (−29.82%)
Aug 10, 2026
11w ago
8-K
BEARISH ★ 5/10
$1.21 $1.15▲ +4.96%▲ +3.90%$0.8000 (+33.88%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8000 (−34.96%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8000 (−34.96%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8000 (−34.96%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8000 (−34.96%)
Jun 10, 2026
19w ago
Insider Cluster
NEUTRAL ★ 2/10
$1.23 $1.26▲ +2.44%▼ −1.18%$0.8000 (−34.96%)
May 11, 2026
24w ago
8-K
NEUTRAL ★ 4/10
$1.35 $1.23▼ −8.89%▼ −7.16%$0.8000 (−40.74%)
May 11, 2026
24w ago
Press Release
BEARISH ★ 6/10
$1.35 $1.23▲ +8.89%▲ +7.16%$0.8000 (+40.74%)
Apr 27, 2026
26w ago
DEFA14A
NEUTRAL ★ 2/10
$1.44 $1.36▼ −5.56%▼ −11.02%$0.8000 (−44.44%)
Showing 10 of 14

US Market Status

Market Closed — Opens in 9h 9m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Apr 27, 2026